Detecting MTC is significantly increased by immunohistochemical detection of CT, carcinoembryonic antigen (CEA), chromogranin A (CgA), and determining CTw levels after FNAB. This evidence concerns the gene CEACAM5 and medullary thyroid gland carcinoma.